FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40690011000001104: Febuxostat 120mg tablets (Crescent Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jun 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2268871000001113 Febuxostat 120mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2268881000001110 Febuxostat 120mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Febuxostat 120mg tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Is a Febuxostat 120mg tablets true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Has specific active ingredient Febuxostat true Inferred relationship Existential restriction modifier
Febuxostat 120mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Febuxostat 120mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Febuxostat 120mg tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start